BioLamina
Chemicals & Related Products · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Löfströms Allé 5, Sundbyberg, Stockholm,...Phone Number
(732) 242-3454Website
www.biolamina.comRevenue
$18.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About BioLamina
BioLamina is a Swedish biotechnology company specializing in the development of full-length human recombinant laminins for cell culture applications. Their products provide a biologically relevant matrix that enhances cell functionality and supports both 2D and 3D cell culture systems. Targeting researchers and clinicians, BioLamina's offerings are designed to meet stringent regulatory requirements, ensuring clinical compliance and reproducible results. With a focus on improving cell performance and differentiation, BioLamina aims to facilitate advancements in cell therapy and regenerative medicine.Explore more
BioLamina Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioLamina your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BioLamina, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioLamina
Check if BioLamina has recently received funding, and reach out quickly before it becomes old news!
Check out if BioLamina is spiking on competitors!
Product Launch: Get notified when BioLamina launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BioLamina recently announced quarterly report
Click to see if BioLamina had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BioLamina has new funding data
Recommended Actions
Find VP level buyers at BioLamina
Find 3 more new buyers
Company Profile Activity
Activity Insights
BioLamina is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioLamina is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioLamina.
BioLamina financials insights
Gather financial insights about BioLamina, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$18.2M
BioLamina Tech Stack
A closer look at the technologies used by BioLamina
See more technologies
Most Recent Scoops
Open Position
Open Position
Funding
Promotion
Executive Move
BioLamina News & Media
Pluristyx and BioLamina Announce Strategic Partnership to Accelerate Development of Stem Cell-Based Therapies
Pluristyx & BioLamina partner to accelerate iPSC-based therapies with integrated cell culture solutions, for consistency, scalability & clinical success.BioLamina Raises €17M in Funding
BioLamina, a Sundbyberg, Sweden-based company which specializes in the development and commercialization of recombinant proteins, raised €17M in funding. The round was led by Lauxera Capital Partners, with participation from Bure Equity, Northislet, as well as with BioLamina’s founders and executives as shareholders. The company intends to use the funds to expand operations and its R&D sector. […] The post BioLamina Raises €17M in Funding appeared first on FinSMEs.Leading Innovators Collaborate to Provide New, Patient Representative Cell Culture Solutions for Smarter In Vitro Research.
WAKEFIELD, Mass.--(BUSINESS WIRE)-- #BioLamina--Cellaria and BioLamina will collaborate to develop novel, patient-specific tissue models for drug screening in oncology and other diseases.Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences
The Swedish government and GE Healthcare are opening Testa Center - an innovation center in Uppsala, Sweden, to boost the commercialization of new technologies and support manufacturing capabilities in the life sciences sector. The 2500 m2 (27,000 sq. ft.) Testa Center houses four bioprocessing laboratories with GE Healthcare technologies for testing new discoveries for the production of biopharmaceuticals, the world's fastest-growing class of medicines. The Swedish government, which... Read
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioLamina
Sign Up For FreeTo access detailed company insights
BioLamina is a Swedish biotechnology company specializing in the development of full-length human recombinant laminins for cell culture applications. Their products provide a biologically relevant matrix that enhances cell functionality and supports both 2D and 3D cell culture systems. Targeting researchers and clinicians, BioLamina's offerings are... Read More
